Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine ORR, lasting at least 4 months, with brentuximab vedotin in patients with CD30+ MF or pcALCL compared to that achieved with therapy in the control arm
Inclusion criteria
- CD30-Positive Cutaneous T-Cell Lymphoma